From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
June 19, 2000
NEW YORK, June 19 (Praxis Press) Most women accept that a false positive result can occur with screening mammography. Few, however, have heard of ductal carcinoma in situ (DCIS), a potentially non-progressive cancer also detected by screening mammography. Schwartz and colleagues surveyed 479 women, aged 18-97 years, without a history of breast cancer (see paper). They found that women are aware of the possibility of false positive results and view them as an acceptab